Regulon, Inc.
Records under this name other than patents Regulon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Regulon, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,278,067 | Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes Lapsed on the fee record Ended Mar 8, 2020 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2020 | From the USPTO record |
| US 6,511,676 | Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes Term ended Term ended Nov 5, 2019 · From the USPTO record | Term ended | Term ended Nov 5, 2019 | From the USPTO record |
| US 6,030,956 | Combination gene therapy for human cancers Term ended Term ended Oct 23, 2017 · From the USPTO record | Term ended | Term ended Oct 23, 2017 | From the USPTO record |
| US 7,393,478 | Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes Lapsed on the fee record Ended Jul 1, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2016 | From the USPTO record |
| US 5,894,060 | Cloning method for trapping human origins of replication Term ended Term ended no later than Apr 13, 2019 · Low confidence | Term ended | Term ended no later than Apr 13, 2019 | Low confidence |